News & Analysis as of

Nanomedicine

Bergeson & Campbell, P.C.

EC JRC Publishes Report on Mapping Nanomedicine Terminology in Regulatory Landscape

The European Commission’s (EC) Joint Research Center has published a Technical Report entitled Mapping Nanomedicine Terminology in the Regulatory Landscape. According to the abstract, to support a better understanding of...more

Bergeson & Campbell, P.C.

NIOSH Announces Paper Outlining Risks to Health Care Workers from Nano-Enabled Medical Products

The National Institute for Occupational Safety and Health (NIOSH) announced that in a paper published May 7, 2015, online ahead of print in the Journal of Occupational and Environmental Hygiene, “NIOSH authors Vladimir...more

Foley & Lardner LLP

Nanomedicine Hitting Its Stride? Beware of Patent Risks

Foley & Lardner LLP on

Though the first nanoparticulate drug formulation was approved by the U.S. FDA way back in 1995, a recent flurry of deals and product approvals have shown increasingly high valuations for nanomedicine companies....more

Foley & Lardner LLP

Nanomedicine Showing its Value … And the Press is Noticing

Foley & Lardner LLP on

The Economist, one of the more worthy media sources these days for connecting technology to larger society, included a page on nanomedicine in its special issue, “The World in 2013.” (page 128)....more

4 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide